Login / Signup

The Application, Challenges, and Advancement Toward Regulatory Acceptance of Digital Toxicologic Pathology: Results of the 7th ESTP International Expert Workshop (September 20-21, 2019).

Vanessa L SchumacherFamke AeffnerErio BaraleCatherine BotteronJonathan CarterLaëtitia EliesJeffery A EngelhardtPierluigi FantThomas ForestAnthony Peter HallDeon HildebrandRobert KlopfleischThomas LucotteHeike Antje MarxfeldLuAnn MckinneyPierre MoulinElizabeth NeyensXavier PalazziAlain PitonElena RiccardiDaniel R RothSerge D RousselleJustin D VidalBethany Williams
Published in: Toxicologic pathology (2020)
With advancements in whole slide imaging technology and improved understanding of the features of pathologist workstations required for digital slide evaluation, many institutions are investigating broad digital pathology adoption. The benefits of digital pathology evaluation include remote access to study or diagnostic case materials and integration of analysis and reporting tools. Diagnosis based on whole slide images is established in human medical pathology, and the use of digital pathology in toxicologic pathology is increasing. However, there has not been broad adoption in toxicologic pathology, particularly in the context of regulatory studies, due to lack of precedence. To address this topic, as well as practical aspects, the European Society of Toxicologic Pathology coordinated an expert international workshop to assess current applications and challenges and outline a set of minimal requirements needed to gain future regulatory acceptance for the use of digital toxicologic pathology workflows in research and development, so that toxicologic pathologists can benefit from digital slide technology.
Keyphrases
  • healthcare
  • endothelial cells
  • fluorescence imaging
  • case control